Page last updated: 2024-11-05

thalidomide and Angiitis, Central Nervous System

thalidomide has been researched along with Angiitis, Central Nervous System in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duzova, A1
Bakkaloglu, A1
Alexandre-Moreira, MS1
Takiya, CM1
de Arruda, LB1
Pascarelli, B1
Gomes, RN1
Castro Faria Neto, HC1
Lima, LM1
Barreiro, EJ1

Reviews

1 review available for thalidomide and Angiitis, Central Nervous System

ArticleYear
Central nervous system involvement in pediatric rheumatic diseases: current concepts in treatment.
    Current pharmaceutical design, 2008, Volume: 14, Issue:13

    Topics: Anticonvulsants; Central Nervous System Diseases; Child; Cyclophosphamide; Drug Therapy, Combination

2008

Other Studies

1 other study available for thalidomide and Angiitis, Central Nervous System

ArticleYear
LASSBio-468: a new achiral thalidomide analogue which modulates TNF-alpha and NO production and inhibits endotoxic shock and arthritis in an animal model.
    International immunopharmacology, 2005, Volume: 5, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Gene Expression; Indoles; Isoindoles; Li

2005